Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125738702 | 12573870 | 2 | F | 20160919 | 20160720 | 20160923 | EXP | US-PFIZER INC-2016347948 | PFIZER | 63.00 | YR | F | Y | 59.00000 | KG | 20160923 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125738702 | 12573870 | 1 | PS | REVATIO | SILDENAFIL CITRATE | 1 | Oral | 40 MG, 3X/DAY, 20MG 2 TABLETS | U | 21845 | 40 | MG | FILM-COATED TABLET | TID | |||||
| 125738702 | 12573870 | 2 | C | CELEXA | CITALOPRAM HYDROBROMIDE | 1 | Oral | 20 MG, DAILY | 0 | 20 | MG | ||||||||
| 125738702 | 12573870 | 3 | C | PREDNISONE. | PREDNISONE | 1 | Oral | 5 MG, 2X/DAY | 0 | 5 | MG | BID | |||||||
| 125738702 | 12573870 | 4 | C | AMBIEN | ZOLPIDEM TARTRATE | 1 | Oral | 10 MG, 1X/DAY, AT BEDTIME | 0 | 10 | MG | QD | |||||||
| 125738702 | 12573870 | 5 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 40 MG, UNK, 1-2 IN THE MORNING AND 1 IN THE EVENING | 0 | 40 | MG | |||||||||
| 125738702 | 12573870 | 6 | C | PLAVIX | CLOPIDOGREL BISULFATE | 1 | 75 MG, 1X/DAY | 0 | 75 | MG | QD | ||||||||
| 125738702 | 12573870 | 7 | C | REQUIP | ROPINIROLE HYDROCHLORIDE | 1 | 0.25 MG, UNK, 1-2 TABLETS AT BEDTIME | 0 | .25 | MG | TABLET | ||||||||
| 125738702 | 12573870 | 8 | C | MEGESTROL | MEGESTROL | 1 | 80 MG, 1X/DAY, 40MG 2 TABLETS EVERY MORNING | 0 | 80 | MG | TABLET | QD | |||||||
| 125738702 | 12573870 | 9 | C | DIGOXIN. | DIGOXIN | 1 | 0.125 UG, DAILY | 0 | .125 | UG | |||||||||
| 125738702 | 12573870 | 10 | C | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | Oral | 25 MG, 1X/DAY | 0 | 25 | MG | QD | |||||||
| 125738702 | 12573870 | 11 | C | IPRATROPIUM BROMIDE. | IPRATROPIUM BROMIDE | 1 | 0.025 %, 3X/DAY, 1 VIAL | 0 | .025 | PCT | TID | ||||||||
| 125738702 | 12573870 | 12 | C | LORAZEPAM. | LORAZEPAM | 1 | 0.5 MG, AS NEEDED, EVERY 6 HOURS | 0 | .5 | MG | TABLET | ||||||||
| 125738702 | 12573870 | 13 | C | DILTIAZEM. | DILTIAZEM | 1 | 60 MG, UNK, 30MG 2 TABLETS EVERY 6 HOURS | 0 | 60 | MG | TABLET | ||||||||
| 125738702 | 12573870 | 14 | C | TOUJEO | INSULIN GLARGINE | 1 | Subcutaneous | 5 IU, DAILY | 0 | 5 | IU | ||||||||
| 125738702 | 12573870 | 15 | C | ALBUTEROL SULFATE. | ALBUTEROL SULFATE | 1 | 1 DF, AS NEEDED, 0.0583 NEBULIZER SOLUTION 1 VIAL EVERY 4-6 HOURS | 0 | 1 | DF | NEBULISER SOLUTION | ||||||||
| 125738702 | 12573870 | 16 | C | ALBUTEROL SULFATE. | ALBUTEROL SULFATE | 1 | 0 | NEBULISER SOLUTION | |||||||||||
| 125738702 | 12573870 | 17 | C | ALBUTEROL SULFATE. | ALBUTEROL SULFATE | 1 | 0 | NEBULISER SOLUTION | |||||||||||
| 125738702 | 12573870 | 18 | C | KLOR-CON | POTASSIUM CHLORIDE | 1 | 20 MEQ, DAILY, 10 MEQ 2 TABLETS | 0 | 20 | MEQ | |||||||||
| 125738702 | 12573870 | 19 | C | MORPHINE | MORPHINE | 1 | UNK UNK, AS NEEDED, LIQUID EVERY 2 HOURS | 0 | |||||||||||
| 125738702 | 12573870 | 20 | C | OXYGEN. | OXYGEN | 1 | 5 L, UNK, PER MINUTE | 0 | 5 | L | |||||||||
| 125738702 | 12573870 | 21 | C | OXYGEN. | OXYGEN | 1 | 0 | ||||||||||||
| 125738702 | 12573870 | 22 | C | OXYGEN. | OXYGEN | 1 | 0 | ||||||||||||
| 125738702 | 12573870 | 23 | C | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | 2.5 UG, DAILY, 2 SPRAYS | 0 | 2.5 | UG | |||||||||
| 125738702 | 12573870 | 24 | C | BROVANA | ARFORMOTEROL TARTRATE | 1 | 1 DF, 2X/DAY, 15MCG/2ML NEBULIZER 1 VIAL TWICE DAILY | 0 | 1 | DF | NEBULISER LIQUID | BID | |||||||
| 125738702 | 12573870 | 25 | C | PULMICORT TURBUHALER | BUDESONIDE | 1 | 1 DF, 2X/DAY, 0.5MG/2ML VIAL 1 VIAL | 0 | 1 | DF | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125738702 | 12573870 | 1 | Pulmonary hypertension |
| 125738702 | 12573870 | 2 | Affective disorder |
| 125738702 | 12573870 | 4 | Insomnia |
| 125738702 | 12573870 | 5 | Oedema |
| 125738702 | 12573870 | 7 | Restless legs syndrome |
| 125738702 | 12573870 | 11 | Chronic obstructive pulmonary disease |
| 125738702 | 12573870 | 12 | Anxiety |
| 125738702 | 12573870 | 14 | Diabetes mellitus |
| 125738702 | 12573870 | 15 | Dyspnoea |
| 125738702 | 12573870 | 16 | Wheezing |
| 125738702 | 12573870 | 17 | Cough |
| 125738702 | 12573870 | 19 | Dyspnoea |
| 125738702 | 12573870 | 20 | Chronic obstructive pulmonary disease |
| 125738702 | 12573870 | 21 | Pulmonary hypertension |
| 125738702 | 12573870 | 22 | Pulmonary fibrosis |
| 125738702 | 12573870 | 23 | Chronic obstructive pulmonary disease |
| 125738702 | 12573870 | 24 | Chronic obstructive pulmonary disease |
| 125738702 | 12573870 | 25 | Chronic obstructive pulmonary disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125738702 | 12573870 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125738702 | 12573870 | Pulmonary fibrosis | |
| 125738702 | 12573870 | Pulmonary hypertension | |
| 125738702 | 12573870 | Respiratory failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125738702 | 12573870 | 1 | 20150817 | 0 | ||
| 125738702 | 12573870 | 11 | 201508 | 0 | ||
| 125738702 | 12573870 | 15 | 201509 | 0 | ||
| 125738702 | 12573870 | 20 | 201509 | 0 | ||
| 125738702 | 12573870 | 23 | 201509 | 0 | ||
| 125738702 | 12573870 | 24 | 201509 | 0 | ||
| 125738702 | 12573870 | 25 | 201509 | 0 |